Calcium Signaling and Cardiac Arrhythmias.
暂无分享,去创建一个
[1] M. Allessie,et al. Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. , 2009, Journal of molecular and cellular cardiology.
[2] M. Ackerman,et al. Molecular evolution of the junctophilin gene family. , 2009, Physiological genomics.
[3] R. Haworth,et al. Abnormal Ca2+ Release, but Normal Ryanodine Receptors, in Canine and Human Heart Failure , 2002, Circulation research.
[4] G. Tomaselli,et al. Mechanisms of Disease: ion channel remodeling in the failing ventricle , 2008, Nature Clinical Practice Cardiovascular Medicine.
[5] Michael J Ackerman,et al. Nature Genetics Advance Online Publication Genetic Association Study of Qt Interval Highlights Role for Calcium Signaling Pathways in Myocardial Repolarization , 2022 .
[6] S. Middha,et al. Homozygous/Compound Heterozygous Triadin Mutations Associated With Autosomal-Recessive Long-QT Syndrome and Pediatric Sudden Cardiac Arrest: Elucidation of the Triadin Knockout Syndrome , 2015, Circulation.
[7] J. Nerbonne,et al. Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics , 2017, The Journal of physiology.
[8] Michael J Ackerman,et al. A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long-QT Syndrome , 2017, Circulation research.
[9] F. Mason,et al. Late INa increases diastolic SR-Ca2+-leak in atrial myocardium by activating PKA and CaMKII , 2015, Cardiovascular research.
[10] Natalia A. Trayanova,et al. Mechanisms of arrhythmogenesis related to calcium-driven alternans in a model of human atrial fibrillation , 2016, Scientific Reports.
[11] Dobromir Dobrev,et al. Role of RyR2 Phosphorylation in Heart Failure and Arrhythmias: Controversies Around Ryanodine Receptor Phosphorylation in Cardiac Disease , 2014, Circulation research.
[12] Veniamin Y Sidorov,et al. Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. , 2008, The Journal of clinical investigation.
[13] M. Gollob,et al. Sudden Death in a Young Man with Catecholaminergic Polymorphic Ventricular Tachycardia and Paroxysmal Atrial Fibrillation , 2008, Journal of cardiovascular electrophysiology.
[14] Niels Voigt,et al. Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. , 2014, The Journal of clinical investigation.
[15] Y. Ohya,et al. Stretch‐Activated Whole‐Cell Currents in Smooth Muscle Cells from Mesenteric Resistance Artery of Guinea‐Pig , 1997, The Journal of physiology.
[16] Henry M Colecraft,et al. L-type calcium channel targeting and local signalling in cardiac myocytes. , 2013, Cardiovascular research.
[17] Alan Garfinkel,et al. Perspective: a dynamics-based classification of ventricular arrhythmias. , 2015, Journal of molecular and cellular cardiology.
[18] J. Seidman,et al. Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy , 1995, Nature Genetics.
[19] M. Ackerman,et al. Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. , 2016, The American journal of cardiology.
[20] Wei Zhang,et al. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy , 2006, Proceedings of the National Academy of Sciences.
[21] M. Mongillo,et al. Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. , 2010, The Journal of clinical investigation.
[22] S. Houser,et al. Hyperphosphorylation of the Cardiac Ryanodine Receptor at Serine 2808 Is Not Involved in Cardiac Dysfunction After Myocardial Infarction , 2012, Circulation research.
[23] Michael J Ackerman,et al. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. , 2005, Heart rhythm.
[24] Mark E. Anderson,et al. Proarrhythmic Defects in Timothy Syndrome Require Calmodulin Kinase II , 2008, Circulation.
[25] A. Scholten,et al. SPEG (Striated Muscle Preferentially Expressed Protein Kinase) Is Essential for Cardiac Function by Regulating Junctional Membrane Complex Activity , 2016, Circulation research.
[26] J. Towbin,et al. Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. , 2013, Journal of the American College of Cardiology.
[27] Donald M. Bers,et al. Excitation-Contraction Coupling and Cardiac Contractile Force , 2001, Developments in Cardiovascular Medicine.
[28] Margaret L. Karst,et al. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology , 2008, Clinical genetics.
[29] D. Szczesna,et al. Abnormal Contractile Function in Transgenic Mice Expressing a Familial Hypertrophic Cardiomyopathy-linked Troponin T (I79N) Mutation* , 2001, The Journal of Biological Chemistry.
[30] I. Rayment,et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle , 1996, Nature Genetics.
[31] Y. Ishikawa,et al. Junctophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies. , 2004, Biochemical and biophysical research communications.
[32] S. Nattel,et al. Role of Small-Conductance Calcium-Activated Potassium Channels in Atrial Electrophysiology and Fibrillation in the Dog , 2014, Circulation.
[33] I. V. Van Gelder,et al. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. , 1999, Cardiovascular research.
[34] Michael Christiansen,et al. Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. , 2012, American journal of human genetics.
[35] Heping Cheng,et al. Catecholaminergic-induced arrhythmias in failing cardiomyocytes associated with human HRCS96A variant overexpression. , 2011, American journal of physiology. Heart and circulatory physiology.
[36] C. Fahrenbruch,et al. Incidence, Causes, and Survival Trends From Cardiovascular-Related Sudden Cardiac Arrest in Children and Young Adults 0 to 35 Years of Age: A 30-Year Review , 2012, Circulation.
[37] J. Gardin,et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.
[38] Colleen E Clancy,et al. L-type Ca2+ channel mutations and T-wave alternans: a model study. , 2007, American journal of physiology. Heart and circulatory physiology.
[39] Y. Oade,et al. Arrhythmogenic right ventricular cardiomyopathy , 2011, BMJ Case Reports.
[40] J. Potter,et al. A Mutation in TNNC1-encoded Cardiac Troponin C, TNNC1-A31S, Predisposes to Hypertrophic Cardiomyopathy and Ventricular Fibrillation* , 2012, The Journal of Biological Chemistry.
[41] A. Wilde,et al. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. , 2011, Journal of the American College of Cardiology.
[42] R. Moss,et al. Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart , 1999, The Journal of physiology.
[43] I. Marty. Triadin regulation of the ryanodine receptor complex , 2015, The Journal of physiology.
[44] R. Vasan,et al. Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012 , 2017, Circulation.
[45] E. Haan,et al. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia. , 2016, Heart rhythm.
[46] Y. Shimoni,et al. K201 (JTV519) suppresses spontaneous Ca2+ release and [3H]ryanodine binding to RyR2 irrespective of FKBP12.6 association. , 2007, The Biochemical journal.
[47] Donald M Bers,et al. Optical Mapping of Sarcoplasmic Reticulum Ca2+ in the Intact Heart: Ryanodine Receptor Refractoriness During Alternans and Fibrillation , 2014, Circulation research.
[48] Sandor Györke,et al. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. , 2004, Biophysical journal.
[49] J. Kere,et al. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. , 1999, Journal of the American College of Cardiology.
[50] Marielle Alders,et al. A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence. , 2014, Journal of the American College of Cardiology.
[51] James O. Mudd,et al. An abnormal Ca2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathy , 2000 .
[52] S. Huke,et al. Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation–contraction coupling, and cardiac arrhythmias , 2009, Proceedings of the National Academy of Sciences.
[53] Joshua T Maxwell,et al. Refractoriness of sarcoplasmic reticulum Ca2+ release determines Ca2+ alternans in atrial myocytes. , 2012, American journal of physiology. Heart and circulatory physiology.
[54] Michael Fill,et al. The Arrhythmogenic Calmodulin p.Phe142Leu Mutation Impairs C-domain Ca2+ Binding but Not Calmodulin-dependent Inhibition of the Cardiac Ryanodine Receptor* , 2016, The Journal of Biological Chemistry.
[55] X. Wehrens,et al. Atrial arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia – is there a mechanistic link between sarcoplasmic reticulum Ca2+ leak and re‐entry? , 2013, Acta physiologica.
[56] David J. Anderson,et al. Ventromedial hypothalamic neurons control a defensive emotion state , 2015, eLife.
[57] K. Campbell,et al. Purification and characterization of calsequestrin from canine cardiac sarcoplasmic reticulum and identification of the 53,000 dalton glycoprotein. , 1983, The Journal of biological chemistry.
[58] S. Nattel,et al. Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs. , 2001, Cardiovascular research.
[59] F C Stevens,et al. Calmodulin: an introduction. , 1983, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.
[60] G. Veglia,et al. Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban , 2013, Proceedings of the National Academy of Sciences.
[61] N. Kaneko,et al. Inhibition of annexin V-dependent Ca2+ movement in large unilamellar vesicles by K201, a new 1,4-benzothiazepine derivative. , 1997, Biochimica et biophysica acta.
[62] H. Wellens,et al. Novel Insights in the Congenital Long QT Syndrome , 2002, Annals of Internal Medicine.
[63] S. Nattel,et al. Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation , 2016, Nature Reviews Cardiology.
[64] G. Dorn,et al. The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy , 2008, European heart journal.
[65] D TEARE,et al. ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS , 1958, British heart journal.
[66] D. Tester,et al. Role of Genetic Testing for Sudden Death Predisposing Heart Conditions in Athletes , 2011 .
[67] Kerstin Dudas,et al. Trends in Out-of-Hospital Deaths Due to Coronary Heart Disease in Sweden (1991 to 2006) , 2011, Circulation.
[68] Dobromir Dobrev,et al. Calcium‐mediated cellular triggered activity in atrial fibrillation , 2017, The Journal of physiology.
[69] Simon Capewell,et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.
[70] E. Olson,et al. Cardiac plasticity. , 2008, The New England journal of medicine.
[71] Carolyn Y. Ho,et al. Is Genotype Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy? Genetics and Clinical Destiny: Improving Care in Hypertrophic Cardiomyopathy Response by Landstrom on P 2440 Genetics of Hcm Controversies in Cardiovascular Medicine , 2022 .
[72] G. Dorn,et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. , 2003, The Journal of clinical investigation.
[73] U. Schotten,et al. Early subcellular Ca2+ remodelling and increased propensity for Ca2+ alternans in left atrial myocytes from hypertensive rats. , 2015, Cardiovascular research.
[74] N. Weissman,et al. Inotropic Stimulation Induces Cardiac Dysfunction in Transgenic Mice Expressing a Troponin T (I79N) Mutation Linked to Familial Hypertrophic Cardiomyopathy* , 2001, The Journal of Biological Chemistry.
[75] Takeo Tanaami,et al. Difference in propagation of Ca2+ release in atrial and ventricular myocytes. , 2005, The Japanese journal of physiology.
[76] M. Horie,et al. Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[77] Amy D. Hanna,et al. Proteins within the intracellular calcium store determine cardiac RyR channel activity and cardiac output , 2012, Clinical and experimental pharmacology & physiology.
[78] R. Matsuoka,et al. Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy. , 2003, Biochemical and biophysical research communications.
[79] A. Børglum,et al. α-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy , 1999 .
[80] Alan Garfinkel,et al. Spatially discordant alternans in cardiac tissue: role of calcium cycling. , 2005, Circulation research.
[81] M. Iino,et al. Junctophilins: a novel family of junctional membrane complex proteins. , 2000, Molecular cell.
[82] Mark A. Magnuson,et al. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy , 2002, Nature.
[83] Leif Hove-Madsen,et al. Atrial Fibrillation Is Associated With Increased Spontaneous Calcium Release From the Sarcoplasmic Reticulum in Human Atrial Myocytes , 2004, Circulation.
[84] X. Wehrens,et al. Targeting ryanodine receptors for anti-arrhythmic therapy , 2011, Acta Pharmacologica Sinica.
[85] C. Heizmann,et al. Ca2+ -dependent interaction of S100A1 with the sarcoplasmic reticulum Ca2+ -ATPase2a and phospholamban in the human heart. , 2003, Biochemical and biophysical research communications.
[86] N. Kaneko,et al. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization. , 2007, European journal of pharmacology.
[87] D. Bers,et al. Protein Kinase A Phosphorylation of the Ryanodine Receptor Does Not Affect Calcium Sparks in Mouse Ventricular Myocytes , 2002, Circulation research.
[88] P. Kirchhof,et al. Familial Hypertrophic Cardiomyopathy-Linked Mutant Troponin T Causes Stress-Induced Ventricular Tachycardia and Ca2+-Dependent Action Potential Remodeling , 2003, Circulation research.
[89] Stephen H. Smith,et al. Gene-Targeted Mice with the Human Troponin T R141W Mutation Develop Dilated Cardiomyopathy with Calcium Desensitization , 2016, PloS one.
[90] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[91] Saumya Das,et al. Development of dilated cardiomyopathy and impaired calcium homeostasis with cardiac-specific deletion of ESRRβ. , 2017, American journal of physiology. Heart and circulatory physiology.
[92] S. Priori,et al. CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism , 2004, Cell.
[93] M. Faggioni,et al. Calsequestrin Mutations and Catecholaminergic Polymorphic Ventricular Tachycardia , 2012, Pediatric Cardiology.
[94] W. Catterall. Correction for Fu et al., Phosphorylation sites required for regulation of cardiac calcium channels in the fight-or-flight response , 2014, Proceedings of the National Academy of Sciences.
[95] D. Dobrev,et al. Function and regulation of serine/threonine phosphatases in the healthy and diseased heart. , 2013, Journal of molecular and cellular cardiology.
[96] E. Schulze-Bahr,et al. Gain-of-function mutations in the calcium channel CACNA1C (Cav1.2) cause non-syndromic long-QT but not Timothy syndrome. , 2015, Journal of molecular and cellular cardiology.
[97] D. Zipes. Mechanisms of Clinical Arrhythmias , 2003, Pacing and clinical electrophysiology : PACE.
[98] S. Solomon,et al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. , 1989, The New England journal of medicine.
[99] D. Bers. Cardiac excitation–contraction coupling , 2002, Nature.
[100] M. Ackerman,et al. Is Genotype Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy? Mutation Type Is Not Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy Response by Ho on P 2450 Controversies in Cardiovascular Medicine , 2022 .
[101] D. Bers,et al. Ca2+/Calmodulin–Dependent Protein Kinase Modulates Cardiac Ryanodine Receptor Phosphorylation and Sarcoplasmic Reticulum Ca2+ Leak in Heart Failure , 2005, Circulation research.
[102] M. Ackerman,et al. Dysferlin, Annexin A1, and Mitsugumin 53 Are Upregulated in Muscular Dystrophy and Localize to Longitudinal Tubules of the T-System With Stretch , 2011, Journal of neuropathology and experimental neurology.
[103] Colleen E. Clancy,et al. In silico prediction of drug therapy in catecholaminergic polymorphic ventricular tachycardia , 2015, The Journal of physiology.
[104] D. Sanoudou,et al. Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase. , 2007, American journal of physiology. Heart and circulatory physiology.
[105] G. Lip,et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[106] S. Ogawa,et al. Development of Newer Calcium Channel Antagonists , 2009, Drugs.
[107] M. Keating,et al. Long QT syndrome associated with syndactyly identified in females. , 1995, The American journal of cardiology.
[108] X. Wehrens,et al. Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. , 2008, Heart rhythm.
[109] Kirsi Penttinen,et al. Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models , 2015, PloS one.
[110] S. Ommen,et al. Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C. , 2007, Journal of molecular and cellular cardiology.
[111] J. Seidman,et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. , 1992, The New England journal of medicine.
[112] Biykem Bozkurt,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[113] M. Keating,et al. MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia , 1999, Cell.
[114] C. Ward,et al. Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. , 2008, The Journal of clinical investigation.
[115] M. Komajda,et al. Familial hypertrophic cardiomyopathy: the same mutation, different prognosis. Comparison of two families with a long follow-up. , 2003, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[116] B. Knollmann,et al. Triple mode of action of flecainide in catecholaminergic polymorphic ventricular tachycardia. , 2013, Cardiovascular research.
[117] M. Rosen,et al. Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation , 2005, Circulation.
[118] A. Leenhardt,et al. Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human , 2012, Human molecular genetics.
[119] Wenjun Xie,et al. Calcium Leak Through Ryanodine Receptors Leads to Atrial Fibrillation in 3 Mouse Models of Catecholaminergic Polymorphic Ventricular Tachycardia , 2012, Circulation research.
[120] A. J. Williams,et al. Triple mode of action of flecainide in catecholaminergic polymorphic ventricular tachycardia: reply. , 2013, Cardiovascular research.
[121] K. Ueda,et al. A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome , 2000, FEBS letters.
[122] Laura Iop,et al. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia , 2012, EMBO molecular medicine.
[123] X. Wehrens,et al. Junctophilin-2 at the intersection of arrhythmia and pathologic cardiac remodeling. , 2016, Heart Rhythm.
[124] James O. Mudd,et al. An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. , 2000, The Journal of clinical investigation.
[125] J. Fauré,et al. Triadin: what possible function 20 years later? , 2009, The Journal of physiology.
[126] MasafumiYano,et al. Altered Stoichiometry of FKBP12.6 Versus Ryanodine Receptor as a Cause of Abnormal Ca2+ Leak Through Ryanodine Receptor in Heart Failure , 2000 .
[127] G. Breithardt,et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation , 1998, Nature.
[128] S. Ommen,et al. Genetics of hypertrophic cardiomyopathy: one, two, or more diseases? , 2007, Current opinion in cardiology.
[129] S. Priori,et al. FKBP12.6 Deficiency and Defective Calcium Release Channel (Ryanodine Receptor) Function Linked to Exercise-Induced Sudden Cardiac Death , 2003, Cell.
[130] A. Auricchio,et al. True idiopathic ventricular fibrillation in out‐of‐hospital cardiac arrest survivors in the Swiss Canton Ticino: prevalence, clinical features, and long‐term follow‐up , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[131] Na Li,et al. Cellular and Molecular Mechanisms of Atrial Arrhythmogenesis in Patients With Paroxysmal Atrial Fibrillation , 2014, Circulation.
[132] T. Herron,et al. Altered myocyte contractility and calcium homeostasis in alpha-myosin heavy chain point mutations linked to familial dilated cardiomyopathy. , 2017, Archives of biochemistry and biophysics.
[133] Frank B Sachse,et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[134] J. Deharo,et al. Prevalence and significance of rare RYR2 variants in arrhythmogenic right ventricular cardiomyopathy/dysplasia: results of a systematic screening. , 2014, Heart rhythm.
[135] S. Priori,et al. Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia , 2001, Circulation.
[136] Rachael,et al. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. , 2008, Mayo Clinic proceedings.
[137] José Jalife,et al. Arrhythmogenic Mechanisms in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia , 2007, Circulation research.
[138] Shi-Xian Deng,et al. Protection from Cardiac Arrhythmia Through Ryanodine Receptor-Stabilizing Protein Calstabin2 , 2004, Science.
[139] M. Matsuzaki,et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy , 1997, Nature Genetics.
[140] S Ringer,et al. A further Contribution regarding the influence of the different Constituents of the Blood on the Contraction of the Heart , 1883, The Journal of physiology.
[141] R. Hershberger,et al. A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia. , 2015, Cardiovascular research.
[142] S. Priori,et al. Abnormal Calcium Signaling and Sudden Cardiac Death Associated With Mutation of Calsequestrin , 2004, Circulation research.
[143] S. Fleischer,et al. The nature of the modulation of Ca2+ transport as studied by reconstitution of cardiac sarcoplasmic reticulum. , 1986, The Journal of biological chemistry.
[144] C. Napolitano,et al. Phenotypical Manifestations of Mutations in the Genes Encoding Subunits of the Cardiac Voltage–Dependent L-Type Calcium Channel , 2011, Circulation research.
[145] Mark E. Anderson,et al. Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. , 2012, Circulation research.
[146] Thomas Meitinger,et al. Calmodulin Mutations Associated With Recurrent Cardiac Arrest in Infants , 2013, Circulation.
[147] X. Wehrens,et al. Defects in Ankyrin-Based Membrane Protein Targeting Pathways Underlie Atrial Fibrillation , 2011, Circulation.
[148] A. J. Williams,et al. Physiological consequences of the P2328S mutation in the ryanodine receptor (RyR2) gene in genetically modified murine hearts , 2008, Acta physiologica.
[149] E. Homsher,et al. Regulation of contraction in striated muscle. , 2000, Physiological reviews.
[150] M. Yano,et al. A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure. , 2003, American journal of physiology. Heart and circulatory physiology.
[151] A. Scholten,et al. Alterations in the interactome of serine/threonine protein phosphatase type-1 in atrial fibrillation patients. , 2015, Journal of the American College of Cardiology.
[152] C. D. dos Remedios,et al. Ryanodine receptor modification and regulation by intracellular Ca2+ and Mg2+ in healthy and failing human hearts. , 2017, Journal of molecular and cellular cardiology.
[153] X. Wehrens,et al. Ryanodine receptor phosphorylation, calcium/calmodulin-dependent protein kinase II, and life-threatening ventricular arrhythmias. , 2011, Trends in cardiovascular medicine.
[154] Min Zhang,et al. Identification of MicroRNA‐mRNA Dysregulations in Paroxysmal Atrial Fibrillation , 2015, International journal of cardiology.
[155] M. Ackerman,et al. Beyond the cardiac myofilament: hypertrophic cardiomyopathy- associated mutations in genes that encode calcium-handling proteins. , 2012, Current molecular medicine.
[156] A. Børglum,et al. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. , 1999, The Journal of clinical investigation.
[157] G. Meissner,et al. Molecular Basis of Calmodulin Binding to Cardiac Muscle Ca2+ Release Channel (Ryanodine Receptor)* , 2003, Journal of Biological Chemistry.
[158] K. Chien,et al. Reversing advanced heart failure by targeting Ca2+ cycling. , 2008, Annual review of medicine.
[159] R. Tsien,et al. A novel type of cardiac calcium channel in ventricular cells , 1985, Nature.
[160] J. Seidman,et al. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. , 2007, The Journal of clinical investigation.
[161] S. Viskin,et al. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. , 2007, Heart rhythm.
[162] M. Ackerman,et al. Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current. , 2016, International journal of cardiology.
[163] Ofer Binah,et al. Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation , 2012, Journal of cellular and molecular medicine.
[164] T. Wieland,et al. Enhanced Sarcoplasmic Reticulum Ca2+ Leak and Increased Na+-Ca2+ Exchanger Function Underlie Delayed Afterdepolarizations in Patients With Chronic Atrial Fibrillation , 2012, Circulation.
[165] Silvia G Priori,et al. Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. , 2011, Circulation research.
[166] X. Wehrens,et al. Animal models of arrhythmogenic cardiomyopathy , 2009, Disease Models & Mechanisms.
[167] Stanley Nattel,et al. Calcium-Handling Abnormalities Underlying Atrial Arrhythmogenesis and Contractile Dysfunction in Dogs With Congestive Heart Failure , 2008, Circulation. Arrhythmia and electrophysiology.
[168] X. Wehrens,et al. Mechanisms of human arrhythmia syndromes: abnormal cardiac macromolecular interactions. , 2007, Physiology.
[169] David W Piston,et al. Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. , 2010, Journal of molecular and cellular cardiology.
[170] L. Eckardt,et al. Triggered activity in atrial myocytes is influenced by Na+/Ca2+ exchanger activity in genetically altered mice. , 2016, Journal of molecular and cellular cardiology.
[171] D. Burkhoff,et al. PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor) Defective Regulation in Failing Hearts , 2000, Cell.
[172] J. Gummert,et al. Antiarrhythmic effects of dantrolene in human diseased cardiomyocytes. , 2017, Heart rhythm.
[173] Daniel Levy,et al. Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.
[174] M. Morad,et al. Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects. , 2013, Cell calcium.
[175] A. Noma,et al. EAD and DAD mechanisms analyzed by developing a new human ventricular cell model. , 2014, Progress in biophysics and molecular biology.
[176] KerstinDudas,et al. Trends in Out-of-Hospital Deaths Due to Coronary Heart Disease in Sweden (1991 to 2006) , 2011 .
[177] D. Roden,et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans , 2009, Nature Medicine.
[178] D. Dobrev,et al. Calcium Handling Abnormalities as a Target for Atrial Fibrillation Therapeutics: How Close to Clinical Implementation? , 2015, Journal of cardiovascular pharmacology.
[179] D. Roden,et al. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. , 2006, The Journal of clinical investigation.
[180] A. J. Williams,et al. Flecainide reduces Ca2+ spark and wave frequency via inhibition of the sarcolemmal sodium current , 2013, Cardiovascular research.
[181] Andrew D McCulloch,et al. Nonequilibrium Reactivation of Na+ Current Drives Early Afterdepolarizations in Mouse Ventricle , 2014, Circulation. Arrhythmia and electrophysiology.
[182] J. van der Velden,et al. Alterations in contractile protein composition and function in human atrial dilatation and atrial fibrillation. , 2006, Journal of molecular and cellular cardiology.
[183] Henggui Zhang,et al. Pro-arrhythmogenic effects of CACNA1C G1911R mutation in human ventricular tachycardia: insights from cardiac multi-scale models , 2016, Scientific Reports.
[184] Godfrey L. Smith,et al. Chronic myocardial infarction promotes atrial action potential alternans, afterdepolarizations, and fibrillation , 2013, Cardiovascular research.
[185] Gaetano Santulli,et al. Imaging atrial arrhythmic intracellular calcium in intact heart. , 2013, Journal of molecular and cellular cardiology.
[186] D. Lancet,et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. , 2001, American journal of human genetics.
[187] S. Priori,et al. Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor , 2005, Circulation research.
[188] Michael Eldar,et al. Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations , 2015, Journal of cellular and molecular medicine.
[189] D. Driscoll,et al. Myosin Light Chain Mutation Causes Autosomal Recessive Cardiomyopathy With Mid-Cavitary Hypertrophy and Restrictive Physiology , 2002, Circulation.
[190] G. Salama,et al. Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs. , 2017, International journal of cardiology.
[191] Stephan E. Lehnart,et al. Ca2+/Calmodulin-Dependent Protein Kinase II Phosphorylation Regulates the Cardiac Ryanodine Receptor , 2004, Circulation research.
[192] H. Mabuchi,et al. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. , 2000, Circulation.
[193] G. Dorn,et al. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[194] L. Monserrat,et al. Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN –42 C>G mutation , 2007, European journal of heart failure.
[195] D. Kastner,et al. Autosomal Recessive Catecholamine- or Exercise-Induced Polymorphic Ventricular Tachycardia: Clinical Features and Assignment of the Disease Gene to Chromosome 1p13-21 , 2001, Circulation.
[196] J. Benitah,et al. L-type Ca(2+) current in ventricular cardiomyocytes. , 2010, Journal of molecular and cellular cardiology.
[197] Katriina Aalto-Setälä,et al. Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Reveals Early and Delayed Afterdepolarizations , 2012, PloS one.
[198] J. Neilson,et al. Loss of MicroRNA-106b-25 Cluster Promotes Atrial Fibrillation by Enhancing Ryanodine Receptor Type-2 Expression and Calcium Release , 2014, Circulation. Arrhythmia and electrophysiology.
[199] D. T. Yue,et al. Calmodulin bifurcates the local Ca2+ signal that modulates P/Q-type Ca2+ channels , 2001, Nature.
[200] R. Reithmeier,et al. Characterization of cardiac calsequestrin. , 1987, Biochemistry.
[201] Richard T. Lee,et al. Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium. , 2014, Circulation research.
[202] Dobromir Dobrev,et al. Serine/Threonine Phosphatases in Atrial Fibrillation. , 2017, Journal of molecular and cellular cardiology.
[203] M. Ackerman,et al. CALM3 mutation associated with long QT syndrome. , 2015, Heart rhythm.
[204] D. Terentyev,et al. Sarcoplasmic reticulum Ca²⁺ release is both necessary and sufficient for SK channel activation in ventricular myocytes. , 2014, American journal of physiology. Heart and circulatory physiology.
[205] R. Shephard. Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006 , 2010 .
[206] Brian J. Stevenson,et al. TECRL, a new life‐threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT , 2016, EMBO molecular medicine.
[207] Michael J Ackerman,et al. Novel Timothy syndrome mutation leading to increase in CACNA1C window current. , 2015, Heart rhythm.
[208] L. Fananapazir,et al. Genotype-Phenotpe Correlations in Hypertrophic Cardiomyopathy Insights Provided by Comparisons of Kindreds With Distinct and Identical j3-Myosin Heavy Chain Gene Mutations , 2005 .
[209] R. Hajjar,et al. Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome , 2012, Circulation research.
[210] A. Wilde,et al. A Novel Early Onset Lethal Form of Catecholaminergic Polymorphic Ventricular Tachycardia Maps to Chromosome 7p14‐p22 , 2007, Journal of cardiovascular electrophysiology.
[211] M. Lisanti,et al. Caveolae and caveolin-3 in muscular dystrophy. , 2001, Trends in molecular medicine.
[212] Stephan E Lehnart,et al. Intracellular calcium release and cardiac disease. , 2005, Annual review of physiology.
[213] G. Ellis‐Davies,et al. Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation. , 1995, Science.
[214] M. Ferenczi,et al. The Dilated Cardiomyopathy-Causing Mutation ACTC E361G in Cardiac Muscle Myofibrils Specifically Abolishes Modulation of Ca2+ Regulation by Phosphorylation of Troponin I , 2014, Biophysical journal.
[215] Sanjiv M Narayan,et al. The role of action potential alternans in the initiation of atrial fibrillation in humans: a review and future directions. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[216] C. Luo,et al. Electrophysiological mechanisms of ventricular arrhythmias in relation to Andersen-Tawil syndrome under conditions of reduced IK1: a simulation study. , 2006, American journal of physiology. Heart and circulatory physiology.
[217] H. Duff,et al. Carvedilol and its new analogs suppress arrhythmogenic store overload–induced Ca2+ release , 2011, Nature Medicine.
[218] Carlo Napolitano,et al. Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia , 2002, Circulation.
[219] J. Arthur,et al. Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy. , 2007, Journal of molecular and cellular cardiology.
[220] P. Coumel,et al. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. , 1995, Circulation.
[221] U. Schotten,et al. Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. , 2009, The Journal of clinical investigation.
[222] S. Priori,et al. Purkinje cell calcium dysregulation is the cellular mechanism that underlies catecholaminergic polymorphic ventricular tachycardia. , 2010, Heart rhythm.
[223] S. Fleischer,et al. Selective Binding of FKBP12.6 by the Cardiac Ryanodine Receptor* , 1996, The Journal of Biological Chemistry.
[224] Kuai Yu,et al. Molecular Mechanism for Divergent Regulation of Cav1.2 Ca2+ Channels by Calmodulin and Ca2+-binding Protein-1* , 2005, Journal of Biological Chemistry.
[225] D. Tester,et al. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. , 2005, Heart rhythm.
[226] R. Lazzara,et al. Role of Na+:Ca2+ Exchange Current in Cs+‐Induced Early Afterdepolarizations in Purkinje Fibers , 1994, Journal of cardiovascular electrophysiology.
[227] A. Grace,et al. Atrial arrhythmia, triggering events and conduction abnormalities in isolated murine RyR2‐P2328S hearts , 2013, Acta physiologica.
[228] S. Nattel,et al. The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis. , 2016, Cardiovascular research.
[229] S. Ommen,et al. Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. , 2007, Journal of molecular and cellular cardiology.
[230] D. Bers,et al. Influence of a constitutive increase in myofilament Ca(2+)-sensitivity on Ca(2+)-fluxes and contraction of mouse heart ventricular myocytes. , 2014, Archives of biochemistry and biophysics.
[231] J. Seidman,et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.
[232] K. Sipido,et al. Na/Ca Exchange and Cardiac Ventricular Arrhythmias , 2007, Annals of the New York Academy of Sciences.
[233] P. Kirchhof,et al. Heart-directed Expression of a Human Cardiac Isoform of cAMP-Response Element Modulator in Transgenic Mice* , 2005, Journal of Biological Chemistry.
[234] J. H. Collins,et al. Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. , 1986, The Journal of biological chemistry.
[235] David T. Yue,et al. Mechanism of Local and Global Ca2+ Sensing by Calmodulin in Complex with a Ca2+ Channel , 2008, Cell.
[236] T. Kamp,et al. Caveolae, ion channels and cardiac arrhythmias. , 2008, Progress in biophysics and molecular biology.
[237] Michael J Ackerman,et al. Disrupted Junctional Membrane Complexes and Hyperactive Ryanodine Receptors After Acute Junctophilin Knockdown in Mice , 2011, Circulation.
[238] E. Lakatta,et al. The immunophilin FK506‐binding protein modulates Ca2+ release channel closure in rat heart. , 1997, The Journal of physiology.
[239] A. Gomes,et al. Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function? , 2010, Journal of molecular and cellular cardiology.
[240] Lei Guo,et al. Calreticulin in the heart , 2004, Molecular and Cellular Biochemistry.
[241] W. Chazin,et al. Arrhythmogenic Calmodulin Mutations Affect the Activation and Termination of Cardiac Ryanodine Receptor-mediated Ca2+ Release* , 2015, The Journal of Biological Chemistry.
[242] A. Terzic,et al. Calreticulin secures calcium-dependent nuclear pore competency required for cardiogenesis. , 2016, Journal of molecular and cellular cardiology.
[243] D. Bers,et al. Role of sodium and calcium dysregulation in tachyarrhythmias in sudden cardiac death. , 2015, Circulation research.
[244] H. Fozzard. Cardiac sodium and calcium channels: a history of excitatory currents. , 2002, Cardiovascular research.
[245] J. Seidman,et al. A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.
[246] J. Svendsen,et al. Integration of 60,000 exomes and ACMG guidelines question the role of Catecholaminergic Polymorphic Ventricular Tachycardia‐associated variants , 2017, Clinical genetics.
[247] J. Jalife,et al. Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death. , 2015, Circulation research.
[248] H. Katus,et al. Mechanisms of disease: hypertrophic cardiomyopathy , 2012, Nature Reviews Cardiology.
[249] D. Dobrev. Unique cardiomyocyte ultrastructure in atria: Role of T tubules in subcellular Ca2+ signaling and atrial arrhythmogenesis. , 2017, Heart rhythm.
[250] B. Maron. Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.
[251] K. Campbell,et al. Biochemical characterization of ultrastructural localization of a major junctional sarcoplasmic reticulum glycoprotein (triadin). , 1993, The Journal of biological chemistry.
[252] Christopher N. Johnson,et al. Spectrum and Prevalence of CALM1-, CALM2-, and CALM3-Encoded Calmodulin Variants in Long QT Syndrome and Functional Characterization of a Novel Long QT Syndrome–Associated Calmodulin Missense Variant, E141G , 2016, Circulation. Cardiovascular genetics.
[253] D. V. Van Wagoner,et al. Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart. , 2016, Circulation.
[254] S. Ommen,et al. PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases: summary of the literature and implications for genetic testing. , 2011, American heart journal.
[255] H. Theile,et al. [The heart-hand syndrome. A new variant of disorders of heart conduction and syndactylia including osseous changes in hands and feet]. , 1992, Kinderarztliche Praxis.
[256] Heping Cheng,et al. Calcium sparks. , 2008, Physiological reviews.
[257] S. Prasad,et al. Genetics and genomics of dilated cardiomyopathy and systolic heart failure , 2017, Genome Medicine.
[258] Michael Fill,et al. Mechanism of calsequestrin regulation of single cardiac ryanodine receptor in normal and pathological conditions , 2013, The Journal of general physiology.
[259] S. Houser. Does protein kinase a-mediated phosphorylation of the cardiac ryanodine receptor play any role in adrenergic regulation of calcium handling in health and disease? , 2010, Circulation research.
[260] B. J. Gersh. Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000 , 2008 .
[261] Manuel F. Navedo,et al. Graded Ca2+/calmodulin-dependent coupling of voltage-gated CaV1.2 channels , 2015, eLife.
[262] X. Wehrens,et al. The junctophilin family of proteins: from bench to bedside. , 2014, Trends in molecular medicine.
[263] D. Dobrev,et al. Transverse tubules are a common feature in large mammalian atrial myocytes including human. , 2011, American journal of physiology. Heart and circulatory physiology.
[264] M. Sanguinetti,et al. Mutations in the hminK gene cause long QT syndrome and suppress lKs function , 1997, Nature Genetics.
[265] S. Nattel,et al. Ryanodine Receptor–Mediated Calcium Leak Drives Progressive Development of an Atrial Fibrillation Substrate in a Transgenic Mouse Model , 2014, Circulation.
[266] A. Terzic,et al. Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient‐Derived iPSC Model , 2016, Clinical and translational science.
[267] K. Brown,et al. Mutations of the Cardiac Ryanodine Receptor (RyR2) Gene in Familial Polymorphic Ventricular Tachycardia , 2001, Circulation.
[268] T. Kondo,et al. Overexpression of calreticulin sensitizes SERCA2a to oxidative stress. , 2005, Biochemical and biophysical research communications.
[269] Steven R Houser,et al. Role of RyR2 Phosphorylation in Heart Failure and Arrhythmias: Protein Kinase A–Mediated Hyperphosphorylation of the Ryanodine Receptor at Serine 2808 Does Not Alter Cardiac Contractility or Cause Heart Failure and Arrhythmias , 2014, Circulation research.
[270] Rosy Joshi-Mukherjee,et al. Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes. , 2014, Journal of molecular and cellular cardiology.
[271] M. Yano,et al. Altered Stoichiometry of FKBP12.6 Versus Ryanodine Receptor as a Cause of Abnormal Ca2 Leak Through Ryanodine Receptor in Heart Failure , 2000, Circulation.
[272] Michael J. Ackerman,et al. Identification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals With Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death , 2015, Circulation. Arrhythmia and electrophysiology.
[273] Christine E. Seidman,et al. α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere , 1994, Cell.
[274] S. Priori,et al. Inherited calcium channelopathies in the pathophysiology of arrhythmias , 2012, Nature Reviews Cardiology.
[275] George S. B. Williams,et al. Axial tubule junctions control rapid calcium signaling in atria. , 2016, The Journal of clinical investigation.
[276] U. Schotten,et al. Transient Receptor Potential Canonical-3 Channel–Dependent Fibroblast Regulation in Atrial Fibrillation , 2012, Circulation.
[277] A. Fleckenstein. History of Calcium Antagonists , 1983, Circulation research.
[278] Niels Voigt,et al. Calcium dysregulation in atrial fibrillation: the role of CaMKII , 2014, Front. Pharmacol..
[279] L. Blatter,et al. The mechanisms of calcium cycling and action potential dynamics in cardiac alternans. , 2015, Circulation research.
[280] M. Ackerman,et al. Junctophilin-2 Expression Silencing Causes Cardiocyte Hypertrophy and Abnormal Intracellular Calcium-Handling , 2011, Circulation. Heart failure.
[281] M Miragoli,et al. CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia , 2013, Cell Death and Disease.
[282] M. Ackerman,et al. Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization. , 2013, Journal of the American College of Cardiology.
[283] W. Catterall,et al. Purification of the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules. , 1984, Biochemistry.
[284] Michael J Ackerman,et al. Distinguishing Hypertrophic Cardiomyopathy-Associated Mutations from Background Genetic Noise , 2014, Journal of Cardiovascular Translational Research.
[285] J. Cinca,et al. Prevention of adenosine A2A receptor activation diminishes beat-to-beat alternation in human atrial myocytes , 2015, Basic Research in Cardiology.
[286] Riccardo Olcese,et al. Enhanced Late Na and Ca Currents as Effective Antiarrhythmic Drug Targets , 2017, Front. Pharmacol..
[287] G. Hasenfuss,et al. CaMKII-Dependent Diastolic SR Ca2+ Leak and Elevated Diastolic Ca2+ Levels in Right Atrial Myocardium of Patients With Atrial Fibrillation , 2010, Circulation research.
[288] M. Nishi,et al. Characterization of human junctophilin subtype genes. , 2000, Biochemical and biophysical research communications.
[289] Y. Ikeda,et al. Toward biologically targeted therapy of calcium cycling defects in heart failure. , 2008, Physiology.
[290] P B Corr,et al. Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. , 1990, The American journal of physiology.
[291] Michael A. Burke,et al. Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies , 2016, Scientific Reports.
[292] A. Zima,et al. Inositol‐1,4,5‐trisphosphate‐dependent Ca2+ signalling in cat atrial excitation–contraction coupling and arrhythmias , 2004, The Journal of physiology.
[293] Hong Liu,et al. Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins. , 2006, Journal of the American College of Cardiology.
[294] A. J. Williams,et al. Ryanodine receptor mutations in arrhythmia: The continuing mystery of channel dysfunction , 2010, FEBS letters.
[295] T. Ogura,et al. Inhibitory effects of JTV‐519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea‐pig hearts , 2000, British journal of pharmacology.
[296] D. Stephan,et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.
[297] X. Wehrens,et al. Emerging roles of junctophilin-2 in the heart and implications for cardiac diseases. , 2014, Cardiovascular research.
[298] S. Marx,et al. Phosphorylation-Dependent Regulation of Ryanodine Receptors , 2001, The Journal of cell biology.
[299] Stanley Nattel,et al. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. , 2014, Circulation research.
[300] R. Hauer,et al. Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. , 2011, Journal of the American College of Cardiology.
[301] Niels Voigt,et al. Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression , 2014, Circulation research.
[302] Á. Zarain-Herzberg,et al. Sarcoplasmic reticulum calsequestrins: Structural and functional properties , 1994, Molecular and Cellular Biochemistry.
[303] Stefan Wagner,et al. Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. , 2010, Journal of the American College of Cardiology.